# Codeine in Sickle Cell Disease

> **NCT00174538** · PHASE1,PHASE2 · COMPLETED · sponsor: **PriCara, Unit of Ortho-McNeil, Inc.** · enrollment: 60 (estimated)

## Conditions studied

- Sickle Cell Disease

## Interventions

- **DRUG:** Codeine (30 mg)

## Key facts

- **NCT ID:** NCT00174538
- **Lead sponsor:** PriCara, Unit of Ortho-McNeil, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** —
- **Final completion:** 2005-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2011-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00174538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00174538, "Codeine in Sickle Cell Disease". Retrieved via AI Analytics 2026-09-17 from https://api.ai-analytics.org/clinical/NCT00174538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*